WCM
GILD icon

Westend Capital Management’s Gilead Sciences GILD Stock Holding History

Westend Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$317K Hold
2,271
– – 0.1% 40
2025
Q4 		$279K Hold
2,271
– – 0.08% 39
2025
Q3 		$252K Hold
2,271
– – 0.07% 36
2025
Q2 		$252K Sell
2,271
-139,795
-98% -$14.9M 0.08% 38
2025
Q1 		$15.9M Buy
142,066
+3,424
+2% +$353K 6.05% 4
2024
Q4 		$12.8M Buy
138,642
+57,632
+71% +$5.19M 3.8% 11
2024
Q3 		$6.79M Buy
+81,010
New +$6.18M 2.33% 20

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Westend Capital Management's GILD Position: Q1 2026 in Review

Westend Capital Management held its Gilead Sciences (GILD) position steady in Q1 2026 at 2,271 shares worth $317K. The position accounts for 0.1% of the portfolio, ranked #40.

Westend Capital Management first reported a position in GILD in Q3 2024 and has held it in 7 quarters since. The position peaked at $15.9M in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Westend Capital Management held 2,271 shares of Gilead Sciences worth $317K as of Q1 2026.
  • Westend Capital Management left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.1% of Westend Capital Management's portfolio in Q1 2026, its #40 holding.
  • Westend Capital Management first reported a position in Gilead Sciences in Q3 2024 and has held it in 7 quarters since.
  • Westend Capital Management's Gilead Sciences position peaked at $15.9M in Q1 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Westend Capital Management's 13F filing for Q1 2026, filed 14 Apr 2026.